Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Middle Ear Gas Exchange: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Middle Ear Gas Exchange: 1 US clinical trial tracked, none currently recruiting.

Middle Ear Gas Exchange is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Cuneyt M. Alper, running 1 of these trials.

Enrollment posture brief

Registry condition middle-ear-gas-exchange

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Middle Ear Gas Exchange (thi…0%
Open-enrollment share among volume-matched conditions near Middle Ear Gas Exchange

Middle Ear Gas Exchange has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Middle Ear Gas Exchange on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Middle Ear Gas Exchange is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Cuneyt M. Alper 1 trials

Named interventions

Most-linked intervention names on Middle Ear Gas Exchange records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

6% CO2, 6%O2, balance N2 Drug
1 trials
0%CO2, 6%O2, balance N2 Drug
1 trials
20%CO2, 6%O2, balance N2 Drug
1 trials
6% CO2, 0%O2, balance N2 Drug
1 trials
6%CO2, 25%O2, balance N2 Drug
1 trials

US sites by state

Facility locations filed on Middle Ear Gas Exchange trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Middle Ear Gas Exchange page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Middle Ear Gas Exchange trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cuneyt M. Alper sponsors the most Middle Ear Gas Exchange trials on record, review their full trial history before evaluating a specific study. See Cuneyt M. Alper's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Middle Ear Gas Exchange condition card totals 1 registered trials; most-linked intervention 6% CO2, 6%O2, balance N2; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.